Question, misiu: not to sound too conspiratorial (but in light of the FDA email evidence, I think this a reasonable concern), but do you think there are still people at the FDA who hold Cytodyn in disdain . . . and would purposely try and minimize our effectiveness by limiting our dosage?

At this point, with all our experience with leronlimab, why just not leave it up to Cytodyn to specify our trial parameters, things like dosage?